Thomas Rocco Jr: How AI is Transforming the Management of High Blood Pressure and Cardiovascular Health
Thomas Rocco Jr, Clinical Professor Emeritus of Medicine at University of Rochester Medical Center, shared a post on LinkedIn about a recent article by Fahimeh Varzideh et al, adding:
“This article, published in the journal Hypertension, provides a comprehensive review of how artificial intelligence (AI) is transforming the management of high blood pressure and cardiovascular health.
The authors conclude that while technologies like cuffless monitoring are still maturing, the integration of AI into cardiovascular medicine offers a transformative framework for precision care, potentially leading to earlier diagnosis and significantly improved long-term patient outcomes.
This article demonstrates how AI is shifting hypertension care from a reactive model to a more personalized, predictive and patient-centered approach.
Core Themes and Key Findings:
Continuous and Cuffless Monitoring.
The review highlights the evolution of blood pressure (BP) measurement beyond the traditional inflatable cuff.
AI algorithms (such as Deep Learning and Extreme Gradient Boost) are now being used to estimate BP using data from wearables, including photoplethysmography (PPG) from smartwatches, electrocardiography (ECG), and heart sounds.
Precision Phenotyping and Risk Prediction:
AI’s ability to process ‘big data’—including genetics, proteomics, and socioeconomic factors—allows for better risk stratification.
It can identify specific ‘phenotypes’ or subgroups of hypertension, helping clinicians predict which patients are at a higher risk for complications like stroke, heart failure, or chronic kidney disease.
Personalized Treatment Strategies:
The article discusses how AI can reduce ‘therapeutic inertia’ (the failure to adjust treatment when goals aren’t met).
AI-guided titration algorithms and ‘digital twins’ (virtual physiological models of a patient) can help doctors determine the most effective medication regimens and optimal BP targets for an individual rather than relying on a one-size-fits-all threshold.
Secondary Hypertension and Diagnostics:
Machine learning models are increasingly capable of detecting ‘secondary hypertension’ (high blood pressure caused by another medical condition) and identifying undiagnosed cases by spotting subtle patterns in electronic health records that human clinicians might miss.
Implementation Challenges:
Despite the promise, the authors note several critical hurdles that must be addressed before widespread clinical adoption.
Data Bias and Ethics:
Ensuring algorithms are fair across different racial and ethnic groups.
Interpretability:
Moving away from ‘black box’ models so that clinicians can understand why an AI made a specific recommendation.
Regulatory Hurdles:
The need for standardized validation and oversight of AI-driven medical devices.”
Title: Artificial Intelligence in Cardiovascular Medicine: Focus on Hypertension
Authors: Fahimeh Varzideh, Pasquale Mone, Urna Kansakar, Shivangi Pande, Stanislovas S. Jankauskas, Gaetano Santulli
Read the Full Article on Hypertension
Stay updated on all scientific advances with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers